AdipoGen Life Sciences

PANoptosome Mouse Antibodies Starter Set

CHF 650.00
In stock
AG-44B-0013-KI011 SetCHF 650.00
More Information
Product Details
Product Type Set
Properties
Application Set Other
Specificity

Each antibody in the PANoptosome Mouse Antibodies Starter Set has been thoroughly validated in KO experimental setup and detects endogenous levels of its target protein.

Crossreactivity Mouse
Kit Contains
  • AG-20B-0014      anti-NLRP3/NALP3, mAb (Cryo-2)                            25 µg
  • AG-20B-0042      anti-Caspase-1 (p20) (mouse), mAb (Casper-1)       25 µg
  • AG-25B-0006      anti-Asc, pAb (AL177)                                                25 µg
  • AG-20B-0010      anti-ZBP1, mAb (Zippy-1)                                          25 µg
  • AG-20T-0138      anti-Caspase-8 (mouse), mAb (3B10)                       25 µg

NOTE: All antibodies are supplied at a concentration of 0.5mg/ml in PBS, containing a preservative. 

Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
Manual Download PDF
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description

The PANoptosome Mouse Antibodies Starter Set is an all-in-one solution to study the three key modes of programmed cell death, including pyroptosis, apoptosis and necroptosis using Western blotting application. This antibody starter set comprises our KO extract validated STANDARD antibodies against the key components of the NLRP3 inflammasome including NLRP3, Asc and Caspase-1, the cytosolic RNA/DNA sensor ZBP1 and the apoptosis target caspase-8. These antibodies are used and published by the experts in inflammasome and cell death research. This economic starter set contains enough primary antibodies to perform at least 3 western blot experiments.

Each antibody is available in 100µg catalog sizes for further experiments.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.